| Parkersburg Treatment Center, Llc | |
|
184 Holiday Hills Drive Parkersburg WV 26104-8006 | |
| (304) 420-2400 | |
| (304) 420-9014 |
| Full Name | Parkersburg Treatment Center, Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 184 Holiday Hills Drive, Parkersburg, West Virginia |
| Authorized Official Name and Position | Brian Phillip Farley (VP & SECRETARY) |
| Authorized Official Contact | 6158616000 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Parkersburg Treatment Center, Llc 6183 Paseo Del Norte, Ste 200 Carlsbad CA 92011-1155 Ph: (855) 259-2288 | Parkersburg Treatment Center, Llc 184 Holiday Hills Drive Parkersburg WV 26104-8006 Ph: (304) 420-2400 |
| NPI Number | 1396756078 |
|---|---|
| Provider Enumeration Date | 08/10/2006 |
| Last Update Date | 08/23/2023 |
| Certification Date | 08/23/2023 |
| Medicare PECOS PAC ID | 3678907235 |
|---|---|
| Medicare Enrollment ID | O20230525001642 |
News Archive
Scientists from the Florida campus of The Scripps Research Institute have successfully tested a potent synthetic compound that prevents type 1 diabetes in animal models of the disease.
Scientists at the Carlos III University in Madrid (UC3M) are participating in a European research project designed to study tuberculosis treatments. The objective of the study is to improve diagnostic imaging technology in order to help develop new drugs to treat the disease.
Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that the Company has licensed to Targacept, Inc. the worldwide rights to its nicotinic-receptor based patents and library of preclinical compounds that target the alpha-7 or other nicotinic receptors originally licensed to Cornerstone from the Feinstein Institute for Medical Research.
There is hope for those who miss one night too many or whose children keep them up at night. The unwelcome effects of a bad night's sleep - forgetfulness, impaired mental performance - can be dealt with by reducing the concentration of an enzyme in the brain. These are the conclusions of research published by Rubicon-grant winner Robbert Havekes and colleagues in the 22 October issue of Nature.
The radiation oncologist's mantra is to deliver the maximum dose of radiation to the malignant tumor, while limiting damage to healthy surrounding tissue. In proton therapy, this balance is achieved by using proton particles, accelerated to nearly the speed of light, to mimic the shape of a tumor and effectively deposit their energy within the confines of it with sub-millimeter precision.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396756078 | NPI | - | NPPES |
| Provider Name | Ellen R Brown |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1154368447 PECOS PAC ID: 6507818150 Enrollment ID: I20050211000501 |
News Archive
Scientists from the Florida campus of The Scripps Research Institute have successfully tested a potent synthetic compound that prevents type 1 diabetes in animal models of the disease.
Scientists at the Carlos III University in Madrid (UC3M) are participating in a European research project designed to study tuberculosis treatments. The objective of the study is to improve diagnostic imaging technology in order to help develop new drugs to treat the disease.
Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that the Company has licensed to Targacept, Inc. the worldwide rights to its nicotinic-receptor based patents and library of preclinical compounds that target the alpha-7 or other nicotinic receptors originally licensed to Cornerstone from the Feinstein Institute for Medical Research.
There is hope for those who miss one night too many or whose children keep them up at night. The unwelcome effects of a bad night's sleep - forgetfulness, impaired mental performance - can be dealt with by reducing the concentration of an enzyme in the brain. These are the conclusions of research published by Rubicon-grant winner Robbert Havekes and colleagues in the 22 October issue of Nature.
The radiation oncologist's mantra is to deliver the maximum dose of radiation to the malignant tumor, while limiting damage to healthy surrounding tissue. In proton therapy, this balance is achieved by using proton particles, accelerated to nearly the speed of light, to mimic the shape of a tumor and effectively deposit their energy within the confines of it with sub-millimeter precision.
› Verified 2 days ago
News Archive
Scientists from the Florida campus of The Scripps Research Institute have successfully tested a potent synthetic compound that prevents type 1 diabetes in animal models of the disease.
Scientists at the Carlos III University in Madrid (UC3M) are participating in a European research project designed to study tuberculosis treatments. The objective of the study is to improve diagnostic imaging technology in order to help develop new drugs to treat the disease.
Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that the Company has licensed to Targacept, Inc. the worldwide rights to its nicotinic-receptor based patents and library of preclinical compounds that target the alpha-7 or other nicotinic receptors originally licensed to Cornerstone from the Feinstein Institute for Medical Research.
There is hope for those who miss one night too many or whose children keep them up at night. The unwelcome effects of a bad night's sleep - forgetfulness, impaired mental performance - can be dealt with by reducing the concentration of an enzyme in the brain. These are the conclusions of research published by Rubicon-grant winner Robbert Havekes and colleagues in the 22 October issue of Nature.
The radiation oncologist's mantra is to deliver the maximum dose of radiation to the malignant tumor, while limiting damage to healthy surrounding tissue. In proton therapy, this balance is achieved by using proton particles, accelerated to nearly the speed of light, to mimic the shape of a tumor and effectively deposit their energy within the confines of it with sub-millimeter precision.
› Verified 2 days ago
Parkersburg Neurological Associates Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3803 Emerson Ave, Parkersburg, WV 26104 Phone: 304-485-5041 Fax: 304-485-5678 | |
Parkersburg Addiction Recovery Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2910 Emerson Ave, Parkersburg, WV 26104 Phone: 304-239-5355 | |
Families Forward, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2302 Camden Ave, Parkersburg, WV 26101 Phone: 304-482-6738 | |
New Beginnings Counseling Service Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3501 Emerson Ave, Suite 2 B, Parkersburg, WV 26104 Phone: 304-420-0940 Fax: 304-865-2214 | |
The Counseling House, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 911 Emerson Ave, Parkersburg, WV 26104 Phone: 304-865-5444 Fax: 304-865-5445 | |
William M. Bauer, Phd, Lpc, Crc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3705 Emerson Ave, Parkersburg, WV 26104 Phone: 304-865-0272 Fax: 304-865-0265 | |
Discovery Ridge Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1824 Murdoch Ave, Parkersburg, WV 26101 Phone: 330-259-8813 |